Exercise-Induced Pulmonary Haemorrhage, known throughout the racing world as EIPH or simply “bleeding,” remains one of the most persistent challenges facing performance horses and the people who care for them. The condition affects a staggering proportion of equine athletes, yet the visible signs most owners and trainers watch for represent only a fraction of the true problem. Effective EIPH post race care has evolved considerably, and horsemen and women now have access to strategies that go well beyond the conventional toolkit. This article examines the science behind EIPH, the regulatory realities shaping management decisions in Equestrian, and the emerging role of non-pharmaceutical interventions that support the horse’s natural recovery mechanisms after maximal exertion.
Table of Contents
Understanding EIPH: The “Bleeder’s” Burden
Exercise-Induced Pulmonary Haemorrhage is defined clinically as the presence of blood originating from the lungs and appearing in the airways following strenuous exercise. The mechanism is both straightforward and sobering. During high-intensity work, the equine athlete generates enormous cardiac output and tidal volume. The pulmonary capillaries, delicate structures responsible for gas exchange, are subjected to extreme transmural pressure as the heart pumps blood through the lungs at rates unmatched in any other terrestrial mammal. Add the locomotory impact of galloping, where the horse’s body absorbs concussive forces with every stride, and the capillary walls can rupture, releasing blood into the alveoli and small airways.
The prevalence figures demand attention. Studies examining Thoroughbreds via a single endoscopic examination report EIPH rates between 43 and 75 percent. When researchers scope the same horses after three consecutive races, the numbers climb dramatically: over 80 percent show evidence of bleeding on at least one occasion. Standardbreds, often assumed to be less affected, tell a similar story. Single-examination prevalence sits around 26 percent, but that figure rises to 87 percent when horses are examined after each of three races. The near-universal nature of the condition is further underscored by bronchoalveolar lavage studies, which find hemosiderophages, cells that have ingested blood, in almost every Thoroughbred in active training.
Critically, visible nosebleeds, known as epistaxis, occur in only about five percent of EIPH cases. Less than one percent of affected horses ever show blood at the nostrils. This means the vast majority of bleeding is “silent,” detectable only through tracheobronchoscopic examination performed within a specific window after exercise. For trainers and owners, this reality transforms EIPH from an occasional, dramatic event into a constant, largely invisible threat that demands proactive management rather than reactive treatment.
The Performance and Welfare Imperative for Post-Race Care
The link between EIPH and diminished athletic performance is not anecdotal; it is documented and quantified. A landmark Australian study examined 744 Thoroughbreds racing in Melbourne and established a clear, statistically significant association between the presence and severity of EIPH and poorer race outcomes. Horses showing more than a fleck of blood on endoscopic examination performed measurably worse than their unaffected counterparts. For an industry where margins are measured in fractions of a second and prize money can hinge on a single placing, these findings carry substantial economic weight. The bleeds are graded the same as mucus scores between 1-5 with 5 being most severe.
The diagnostic window for EIPH informs the entire post-race care timeline. Blood is typically detectable by tracheobronchoscopic examination for one to three days following a race, though some horses retain visible evidence for up to seven days. Definitive diagnosis is best achieved by scoping 30 to 120 minutes after exertion, when blood in the trachea or large bronchi is most readily observed. This window is not merely diagnostic; it represents the period during which the horse’s airways are actively managing the aftermath of capillary rupture, clearing blood and inflammatory debris while attempting to restore normal function.
The long-term consequences of untreated, recurrent EIPH extend beyond a single poor performance. Repeated bleeding episodes can lead to pathological changes in lung tissue, including fibrosis and remodelling that permanently compromise respiratory capacity. A horse’s athletic career may be shortened not by a catastrophic single event but by the cumulative toll of subclinical haemorrhage. Post-race care, therefore, is not simply about recovering from the most recent run. It is an investment in the horse’s respiratory future, protecting the elasticity and efficiency of lung tissue across seasons of competition.
The welfare dimension is equally compelling. A horse that bleeds internally with every maximal effort is experiencing a physiological insult that demands attention. The racing industry’s social licence depends, in part, on demonstrating that the animals at its centre receive care that prioritises their wellbeing. Robust post-race protocols that actively support airway healing and reduce the severity of future episodes serve both the performance goals of owners and the ethical obligations the industry carries.
Conventional Management and the Australian Regulatory Landscape
Furosemide, marketed internationally as Lasix or Salix, has long been the pharmaceutical cornerstone of EIPH prevention in jurisdictions that permit its use. The drug acts as a diuretic, reducing plasma volume and, theoretically, the pulmonary capillary pressures that drive haemorrhage. It is widely administered to racehorses in North America and other racing nations. In Australia, however, furosemide is prohibited on race day. This regulatory position creates a fundamentally different management environment, one in which trainers cannot rely on a pre-race injection to mitigate bleeding. The Australian approach demands that respiratory health be built and maintained during training and that post-race recovery be managed without the pharmaceutical tools available elsewhere.
Nasal strips represent one non-pharmaceutical intervention with evidence supporting their use. By mechanically supporting the soft tissues of the nasal passages, these strips reduce airway resistance and the associated pressure swings that contribute to capillary stress. Nutritional strategies also play a role. Omega-3 fatty acids, particularly those found in marine sources, have been studied for their anti-inflammatory properties and potential to support vascular integrity. Antioxidants, including vitamin E and selenium, are commonly incorporated into bleeding management programs to combat the oxidative stress associated with intense exercise and tissue repair.
Veterinary diagnosis follows a standardised protocol. Tracheobronchoscopic examination performed 30 to 120 minutes post-race allows direct visualisation of any blood present in the airways. The severity of EIPH is graded on a scale from zero to three, with grade zero indicating no visible blood and grade three representing severe haemorrhage with blood pooling in the trachea. This grading system provides an objective framework for tracking a horse’s condition over time and evaluating the effectiveness of management strategies.
The ethical dimension of managing known bleeders under Australia’s regulatory framework deserves explicit acknowledgment. Trainers and veterinarians carry the responsibility of monitoring horses for silent EIPH, adjusting training loads and recovery protocols accordingly, and making difficult decisions about a horse’s racing future when bleeding becomes recurrent or severe. The absence of race-day medication does not diminish this responsibility; it amplifies it, placing greater emphasis on the quality of care delivered between races.
The Role of Equine Salt Therapy in Post-Race Rehabilitation
Halotherapy, the therapeutic use of dry salt aerosol in a controlled environment, has emerged as a modality with particular relevance to post-race respiratory care. The mechanism is grounded in the hygroscopic properties of pharmaceutical-grade sodium chloride particles, which are dispersed into the air at respirable sizes, typically between one and five microns. When inhaled, these particles interact with the moist lining of the airways. The salt draws fluid from the mucosal surface, a process that can reduce oedema, thin accumulated mucus, and improve the function of the mucociliary escalator, the microscopic hair-like structures that sweep debris from the lungs.
For the post-race horse recovering from EIPH, this mechanism offers a drug-free means of supporting airway clearance. Residual blood and the inflammatory byproducts it generates can linger in the respiratory tract for days after a bleeding episode. Facilitating their removal may accelerate recovery, reduce secondary inflammation, and help restore normal airway function more rapidly than rest alone. The anti-inflammatory and antimicrobial properties attributed to salt further support the healing environment within the lungs.
The regulatory context makes this approach particularly compelling. With race-day furosemide unavailable, trainers must look to training-based interventions that prepare the horse’s respiratory system to withstand the stresses of racing and recover efficiently afterwards. Equine Salt Therapy fits within this paradigm as a proactive strategy, one that can be integrated into the regular training and recovery cycle without contravening any medication rules. It is not a replacement for veterinary care or sound training practices but an adjunct that addresses a specific physiological need: the maintenance of clean, functional airways in horses asked to perform at their physiological limits.
The adoption of this modality is growing within high-performance stables and dedicated rehabilitation centres internationally. Trainers who incorporate salt therapy into their post-race protocols report observing horses that recover respiratory composure more quickly and maintain more consistent performance across their campaigns. For equine professionals, where the climate and racing calendar place unique demands on horses, the ability to offer controlled respiratory therapy on-site represents a meaningful competitive advantage. This is where Equine Salt Therapy Permanent Installations become relevant for stables and veterinary practices looking to build comprehensive respiratory care capabilities into their facilities. Similarly, Equine Salt Therapy Mobile Business Opportunities allow practitioners to bring the therapy directly to horses at their home stables, reducing transport stress during the critical post-race recovery period. Patent protected for the Welfare of the horse.
Implementing a Salt Therapy Protocol for Your Stable
Integrating salt therapy into a post-race routine requires a structured approach that aligns with the known diagnostic and recovery windows for EIPH. A typical session lasts 45 to 60 minutes, during which the horse stands in a purpose-built salt room or mobile unit where the air is saturated with a controlled concentration of dry salt aerosol. The optimal timing for initiation is 24 to 48 hours post-race, coinciding with the period when blood and inflammatory debris are being actively cleared from the airways. Sessions can be repeated at intervals throughout the recovery week, with frequency adjusted based on the horse’s individual history and the severity of any bleeding observed on scope. My desire is to have this critical care available on Raceday.
Salt therapy should not be viewed in isolation. Its greatest value is realised when integrated into a broader respiratory health program that includes regular endoscopic monitoring, careful tracking of recovery heart rate and respiratory effort, and nutritional support tailored to the individual horse. The data gathered from scoping provides objective feedback on whether the therapy is contributing to reduced bleeding severity over time, allowing protocols to be refined.
When selecting a facility or practitioner, horse owners and trainers should prioritise those with specific experience working with equine athletes. The particle size of the salt aerosol is critical; particles must be small enough to reach the lower airways where EIPH damage occurs. A controlled environment that maintains consistent concentration throughout the session is equally important. For those considering bringing the technology in-house, the Equine Salt Therapy Master License and Licensee models provide pathways for establishing permanent or mobile operations within a defined territory, ensuring consistent access for horses under their care without reliance on external providers. Laser measuring of concentrations per Mg/M3 in the chamber ensures uniformity for safe effective professional care.
Building a Comprehensive Post-Race Respiratory Plan
A well-constructed post-race plan addresses the horse’s respiratory needs across multiple timeframes, each with distinct objectives.
In the immediate post-race period, the first zero to two hours, the focus is on stabilisation. Controlled cool-down with extended walking allows the respiratory rate to decline gradually while maintaining airway clearance. Access to fresh, clean air is essential; horses should not be confined to enclosed spaces where airborne irritants might compound airway inflammation. Observation for any signs of respiratory distress, including prolonged elevation of breathing rate or unusual respiratory sounds, guides decisions about whether veterinary assessment is needed urgently.
The short-term window, spanning 24 to 72 hours post-race, is when diagnostic information should be gathered and active recovery support initiated. If EIPH is suspected based on performance, recovery patterns, or known history, tracheobronchoscopic examination should be scheduled within the optimal diagnostic window. Once the presence and severity of bleeding have been established, the appropriate rest period can be determined and supportive therapies, including salt therapy sessions, can commence to assist with airway clearance and inflammation control. My wishes extend but are not limited to immediate access to the soothing sweeping effects of my invention on Raceday as it was intended. I could not think of a better gift on the Horses birthday than full access to 100% natural Equine Salt Therapy and Ultisalt™
The long-term, ongoing phase extends across the horse’s racing career. Regular monitoring through scoping builds a longitudinal picture of respiratory health, revealing trends that might not be apparent from any single examination. Nutritional support, including omega-3 supplementation and antioxidant provision, is maintained consistently rather than applied only after bleeding is detected. Strategic use of salt therapy as a preventative measure, scheduled around training and racing to maintain optimal respiratory function, becomes part of the horse’s routine rather than a response to crisis. This proactive philosophy represents the best defence against the cumulative effects of EIPH, safeguarding both welfare and performance potential across seasons.
The Future of Equine Respiratory Care
The understanding of EIPH has advanced considerably since the condition was first noted in Thoroughbred racing during the 1600s and 1700s, yet the challenge it presents remains fundamentally unchanged. What has shifted is the range of tools available to manage it and the philosophical approach the industry brings to the task. The trend in Australia and internationally is toward proactive, non-pharmaceutical strategies that support the horse’s own physiological capacities rather than overriding them with medication.
Technologies like Equine Salt Therapy are positioned to become standard components of elite equine care, joining hydrotherapy, physiotherapy, and advanced nutritional science in the modern performance horse’s support system. As research continues to quantify the long-term benefits of maintaining airway health and as the industry’s welfare expectations continue to rise, the integration of respiratory therapy into daily stable management will likely accelerate.
The horses that carry the sport’s hopes, the sprinters and stayers who thrill crowds from Flemington to Randwick and Kentucky to Newmarket deserve care that matches their effort. Respiratory health is not a secondary concern to be addressed only when bleeding becomes visible or performance drops sharply. It is a cornerstone of athletic function, as fundamental as soundness of limb or efficiency of stride. When post-race care is approached with this understanding, when recovery protocols are designed to actively heal and protect the airways, the horse benefits, the stable benefits, and the sport itself is strengthened. The future of equine respiratory care lies in this integration of innovation, evidence, and unwavering commitment to the animal’s wellbeing, long after the finish line has been crossed. Let it be the innovators of this technology be the ones to implement its rollout for this is my life’s work and there is no one more committed to its legacy. Richard Butterworth
